No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Carestream Health Reports Partnership with Ziehm Imaging Americas

Editor: What To Know

  • “The addition of the Ziehm C-arm to our medical imaging portfolio—backed by Carestream's deep experience in radiology and fluoroscopy applications—is another example of our commitment to meet the evolving needs of our customers and their patients,” said Steve Romocki, Worldwide Product Line Manager for Radiology Systems at Carestream.
  • The Ziehm Vision RFD delivers advanced surgical care with the Ziehm Usability Concept, provides exceptional image quality and helps to reduce exposure significantly with the next-generation SmartDose, thereby providing a very unique package.
  • “As a result of this partnership, we’re able to provide Carestream and its customers with one of the most innovative C-arms on the market.

April 19, 2021

Carestream Health in partnership with Ziehm Imaging announced the addition of a mobile C-arm into its growing innovative product portfolio.

Known as the Ziehm Vision RFD C-arm, this surgical imaging system will further enhance Carestream’s mobile and fluoroscopic product offerings to benefit even more healthcare providers. The system will be available in the U.S. and Canada in 2021.

The Vision RFD C-arm offers a 25kw generator, in either a 20.5 x 20.5 cm or 31 x 31 cm field of view flat-panel CMOS digital detector, allowing for broad procedural work including vascular, cardiac, spine ortho-trauma and pain management, in addition to many general surgical applications. The system’s Advanced Active Cooling enables extended case times beyond traditional air-cooled systems. It also provides an intuitive graphical interface that benefits technologists with reduced training time as well as improved productivity.

“The partnership with Carestream Health confirms Ziehm Imaging’s industry-leading technology,” said Nelson Mendes, President and CEO of Orthoscan and Ziehm Imaging Inc. “As a result of this partnership, we’re able to provide Carestream and its customers with one of the most innovative C-arms on the market. The Ziehm Vision RFD delivers advanced surgical care with the Ziehm Usability Concept, provides exceptional image quality and helps to reduce exposure significantly with the next-generation SmartDose, thereby providing a very unique package.”

Ziehm Vision RFD systems will be available for sale and service through Carestream. The company’s Sales & Service team—working in collaboration with Ziehm Imaging—will provide responsive support to all valued customers. Carestream Service is widely recognized for its outstanding customer satisfaction and prompt support.

“The addition of the Ziehm C-arm to our medical imaging portfolio—backed by Carestream’s deep experience in radiology and fluoroscopy applications—is another example of our commitment to meet the evolving needs of our customers and their patients,” said Steve Romocki, Worldwide Product Line Manager for Radiology Systems at Carestream.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy